Related Experiment Video

Updated: Jul 15, 2026

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

CD64 enables TCR-dependent, MHC-independent CTL cytotoxicity of AML cells

Kapil Saxena1, Shao-Hsi Hung2,3, Esther Ryu2

  • 1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

Proceedings of the National Academy of Sciences of the United States of America
|July 13, 2026
PubMed

Insights

Cytotoxic CD8+ T lymphocytes (CTLs) can kill cancer cells independently of peptide-MHC interactions. This study reveals a novel CD64-dependent, TCR-dependent pathway for CTL killing of acute myeloid leukemia (AML) cells.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Cytotoxicity

Background:

  • CD8+ T cell killing typically involves T cell receptor (TCR) engagement with peptide-MHC (pMHC).
  • Tumor cells can be killed by CD8+ T cells via pMHC-independent mechanisms, but the exact pathways remain unclear.
  • Natural killer (NK) cell receptors are often implicated in pMHC-independent cytotoxicity.

Purpose of the Study:

  • To investigate the mechanisms of pMHC-independent cytotoxicity in acute myeloid leukemia (AML).
  • To identify the specific receptors and pathways involved in CD8+ T cell killing of AML cells.
  • To determine the role of CD64 and TCR activation in this process.

Main Methods:

  • Utilized AML as a model system for studying CD8+ T cell cytotoxicity.
  • Employed knockout strategies for potential AML ligands and CD8+ T cell receptors.
  • Analyzed cytotoxicity in relation to CD64 expression and IFNγ regulation.

Main Results:

  • Identified a paradoxical TCR-dependent, MHC-independent mechanism of CD8+ T cell killing of AML cells.
  • Demonstrated that pMHC-independent cytotoxicity is a potent mechanism largely restricted to CD64-expressing cells.
  • Showed that this killing is IFNγ-regulated and requires an activated TCRαβ/CD3 complex, not NK activating receptors.

Conclusions:

  • Discovered a CD64-dependent, pMHC-independent, TCR-dependent mode of CD8+ T cell cytotoxicity.
  • This novel killing mechanism is significantly enriched in AML.
  • Highlights a distinct pathway for CD8+ T cell-mediated anti-leukemia immunity.

Keywords:
AMLCD64CTLMHCTCR

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview